Collplant Biotechnologies

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$164
$4
$249
$98
Gross Profit
-108
-268
-287
-727
EBITDA
-3,732
-4,287
-4,145
-4,049
EBIT
-3,974
-4,542
-4,406
-4,329
Net Income
-3,878
-4,326
-4,210
-4,195
Net Change In Cash
164
4
249
98
Free Cash Flow
-3,523
-3,588
-4,130
-3,335
Cash
11,909
15,371
18,920
23,464
Basic Shares
11,454
11,454
11,454
11,453

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$515
$10,959
$299
$15,641
Gross Profit
-1,110
8,968
-101
13,636
EBITDA
-16,213
-6,410
-16,021
838
EBIT
-17,251
-7,512
-17,097
65
Net Income
-16,609
-7,019
-16,753
409
Net Change In Cash
515
10,959
299
15,641
Free Cash Flow
-14,576
-3,717
-15,014
912
Cash
11,909
26,674
29,653
13,148
Basic Shares
11,454
11,389
11,033
11,966

Earnings Calls

Quarter EPS
2024-12-31
-$0.34
2024-09-30
-$0.38
2024-06-30
-$0.37
2024-03-31
-$0.37